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ABSTRACT
Myxomas  are  benign  primary  tumors  of  the  heart  of  mesenchymal  origin.  Neurological  complications
attributed to atrial myxoma occurs in 10% to 12% of patients, with ischemic presentation due to cerebral
infarct in 83%-89% of cases. Few case reports are available of multiple metastatic myxomas from primary in
the heart, despite its slow growing and innocuous histological appearance. Primary intracranial myxomas
are extremely rare and only six cases have been reported in literature till  date, out of which four were
supratentorial in location. As on account of its benign nature, complete surgical resection of the tumor is the
recommended treatment. 
INTRODUCTION
Myxomas  are  benign  primary  tumors  of  the  heart  of  mesenchymal  origin.  Neurological  complications
attributed to atrial myxoma occurs in 10% to 12% of patients, with ischemic presentation due to cerebral
infarct in 83%-89% of cases. 1, 2, 3 Few case reports are available of multiple metastatic myxomas from
primary in the heart, despite its slow growing and innocuous histological appearance 4. Primary intracranial
myxomas are extremely rare and only six cases have been reported in literature till date, out of which four
were supratentorial in location 1. As on account of its benign nature, complete surgical resection of the tumor
is the recommended treatment.
CASE HISTORY
This 24 year old male presented with two and a half  months history of  holocranial  headache, recurrent
episodes of vertigo and visual deterioration. He does not have other complaints related to cardiovascular
system.
On neurological examination higher mental function was intact. His visual acuity on his right side was 6/18
with left ocular prosthesis. Fundoscopy revealed late stage of papilloedema. Left sided facial hypoesthesia
was there in the distribution of V1, 2, & 3 branches of mandibular nerve, but there was no evidence of any
motor involvement. There was mild hemiparesis on the left side (4+/5), with intact sensations all over the
body. He had left sided cerebellar lobar signs with wide based gait and tendency to fall towards left. There
were  no  cutaneous  stigmata.  His  routine  investigations  were  normal  including  echocardiography.  On
Computerized Tomography scan head, there was large 5x5cm hypodense lesion present in the region of the
middle fossa with extension anteriorly up to temporal tip and posteriorly up to the occipital horn. Lesion was
compressing the midbrain and cerebral peduncle medially with effacement of ipsilateral lateral ventricle and
third ventricle. Superior extension was up to the sylvian fissure and inferior up to the temporal base. It had
irregular  lobulated margins with perilesional edema and midline shift.  The lesion had mild,  homogenous
contrast enhancement.
Magnetic resonance imaging brain revealed a T1W isointense and T2W hyperintense lesion of size 6x5x4
cm with lobulations. The lesion was attached on the left side of the tentorium with evidence of dural tail.
There was significant perilesional edema with mass effect in form of  effacement of  the ipsilateral lateral
ventricle and dilatation of the contralateral lateral ventricle with compression of the midbrain and midline shift
towards right side. Whole enhancing lesion was well demarcated from surrounding parenchyma. [Figure 1]
According to these clinico-radiological features, a diagnosis of left superior tentorial based lesion was made.
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Left temporal craniotomy was done with complete excision of the tumor. Intraoperatively, the tumour was
encountered in the middle fossa region. It had both solid and cystic components with soft to firm consistency,
with soft part easily suckable. There was no evidence of any brain invasion. No dural attachment was evident
during  surgery.  Intraoperative  impression  was  of  meningioma.  Whole  of  the  tumor  was  excised.
Postoperative recovery was uneventful without any fresh neurological deficit. There was gradual improvement
in his headache and vertigo, and he was discharged on 7th postoperative day.
Histopathology revealed it  to be a Myxoma. Immunohistochemistry also revealed positivity for S100 and
vimentin, and negative for epithelial membrane antigen (EMA), Glial fibrillary acidic protein (GFAP), CD34
and desmin. [Figure 2] Ki-67 index is <1%.
DISCUSSION
Myxomas are uncommon benign mesenchymal tumors of the heart which affects young individuals and often
their neurological presentation is in form of stroke, due to tumor emboli. Thus most of the patients with atrial
myxoma  have  initial  manifestation  of  CNS due  to  ischemic  events  5.  Myxoma  has  been described  in
literatures at various places as in gingiva, kidney, breast, bone and various others sites 5.
Occurrence of myxoma in CNS is exceptionally rare. These have been described in some case series as
metastatic lesions from primary atrial myxoma 6. Lee et al reported that 12% of cardiac myxomas have some
form of CNS manifestations2. Most of these are due to embolic phenomenon leading to ischemic cerebral
infarct 2, 3. There are few case reports of multiple CNS metastasis due to tumor embolization from previously
operated atrial myxoma 7.
On review of literature, we found only 6 previously reported case of primary intracranial myxomas 1. One of
those  was  very  similar  to  our  case,  as  convexity  dural  based  lesion  which  mimicked  meningioma
radiologically.  Other  one was arising from cranium with no distinction from bony tumors  8.  In our case,
although there was radiological  evidence of  dural  attachment  but  no dural  attachment  was seen during
surgery. There is wide variation in radiological findings in these lesions (Table 1).
MRI features play a key role to diagnosis for primary as well as secondary myxoma. Myxomas show an
expansile  growing  pattern  frequently  limited  in  the  inner  and  outer  tables  of  the  bone.  They  may  be
hypodense to isodense in CT scans, and show variable enhancement pattern. It usually shows expensile
pattern of the mass as seen in our case. The classical MRI pattern is the heterogeneous composition of the
lesion. The MRI signal characteristics of myxomas are low signal intensity in T1-WI, and hyperintensity with
heterogenicity in T2-WI images. Although in our patient lesion is intense hyperintense in T2-WI, but it shown
homogenous. Clinical presentation and demographic data of myxomas may resemble many other neoplasms
and  vascular  lesions  at  this  site.  Chondrosarcoma,  chordoma,  metastatic  tumors  of  the  skull,
hemangiopericytoma, meningioma and other neoplasms of the dura and skull base are the most frequently
encountered lesions in differential diagnosis.
Total surgical resection follow the same principal with removal of attached dura if found during the surgery.
Total excision should be done as these are benign lesions and it provides excellent prognosis. Even for atrial
myxomas, this surgical principle is followed 8. Immunohistochemistry offers the basis of identification of this
unusual tumor. Histopathology is the key to suspicion with its myxoid material with uniformly scattered spindle
shaped cells having scant cytoplasm 9, 10.
CONCLUSION
Myxomas are rare neoplasms and only 6 cases have been identified till date of primary intracranial myxomas.
Cardiac  myxomas  may  present  as  stroke  due  to  embolism.  Intracranial  location  has  its  own  surgical
indication  with  complete  resection  as  a  goal  of  surgery.  Correct  diagnosis  should  be  based  on
immunohistochemistry to rule out other malignant tumors or metastasis. Further collaborative studies are
needed to identify its origin and to formulate better treatment guidelines.
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Figure 1
Preoperative images, T2W MRI Brain Axial cut showing the lobulated hyperdense mass with septations with
perilesional edema and mass effect (1B), with iso dense nature of lesion in T1W axial (1A) with lobulations
with mass effect over brainstem. Post contrast T1W images showing intense enhancement (axial images),
(1C), with temporal location with broad based attachment to tentorium with dural tail in coronal images (1D).
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Figure 2
Preoperative images, post gadolinium enhancing images showing the broad base of tumor with tentorium
with evidence of dural tail on coronal images (2A), and sagittal images (2B). DWI shows no restriction on
diffusion and ADC map shows hyper intensity of lesion with no restriction.
Figure 3
H&E stained section (200x) shows tumor attached to dura (A). H& E stained section (200x) shows tumour
composed of lobules seperated by thin fibrous septa. The lobules are composed of abundant myxoid material
with some stellate tumor cells displaying small  round to oval nuclei,  dispersed chromatin,  inconspicuous
nucleoli and scant cytoplasm. Occasional foci of mononuclear cell infiltrate composed of lymphocytes and
plasma cells are also seen. No mitosis is seen. Features are suggestive of myxoma (B).
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Table 1: Summary of all case reports of intracranial myxoma 
Authors Age/sex Location Radiological findings 
Surgical
excision 






inhomogeneously enhancing mass Total excision 
Menon  et  al
(1) 25yr / M Left parietal Isodense enhancing mass Total excision 
Klein et al (13) 32yr/ F Posterior fossa inhomogeneously enhancing lesion Excision  extent
not clear 
Kawatra  et  al
(11) 
12yr / M Occipital 
expansile lytic sclerotic lesion arising from
the right occipital bone showing prominent






38yr/ M Intrasellar  &
suprasellar 




34yr/ M Right temoral inhomogeneously  enhancing  mass  lesion
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